Thomas E. Adrian

24.4k total citations · 3 hit papers
512 papers, 19.6k citations indexed

About

Thomas E. Adrian is a scholar working on Surgery, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Thomas E. Adrian has authored 512 papers receiving a total of 19.6k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Surgery, 155 papers in Cellular and Molecular Neuroscience and 154 papers in Molecular Biology. Recurrent topics in Thomas E. Adrian's work include Neuropeptides and Animal Physiology (147 papers), Pancreatic function and diabetes (63 papers) and Receptor Mechanisms and Signaling (45 papers). Thomas E. Adrian is often cited by papers focused on Neuropeptides and Animal Physiology (147 papers), Pancreatic function and diabetes (63 papers) and Receptor Mechanisms and Signaling (45 papers). Thomas E. Adrian collaborates with scholars based in United States, United Kingdom and United Arab Emirates. Thomas E. Adrian's co-authors include Stephen R. Bloom, S.R. Bloom, J. M. Polak, Xianzhong Ding, Kazuhiko Tatemoto, A.J. Bacarese-Hamilton, Weigang Tong, Janet M. Allen, J.M. Allen and J.M. Polak and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Thomas E. Adrian

505 papers receiving 18.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuropeptide Y Distribution in the Rat Brain

1983 970 citations Thomas E. Adrian, S.R. Bloom et al. profile →
Human distribution and release of a putative new gut hormone, peptide YY

1985 867 citations Thomas E. Adrian, Stephen R. Bloom et al. profile →
Neuropeptide Y distribution in human brain

1983 590 citations Thomas E. Adrian, Stephen R. Bloom et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas E. Adrian United States	71	6.5k	6.4k	5.3k	2.8k	2.8k	512	19.6k
Jens F. Rehfeld Denmark	65	4.5k 0.7×	4.3k 0.7×	5.6k 1.1×	1.7k 0.6×	3.7k 1.3×	415	14.9k
Nigel W. Bunnett United States	87	8.4k 1.3×	9.3k 1.4×	3.8k 0.7×	2.2k 0.8×	832 0.3×	358	29.5k
Christoph Beglinger Switzerland	75	1.6k 0.2×	2.6k 0.4×	8.4k 1.6×	2.2k 0.8×	3.7k 1.3×	346	19.9k
Stefan Offermanns Germany	91	5.1k 0.8×	18.1k 2.8×	3.2k 0.6×	2.4k 0.8×	2.4k 0.9×	376	31.8k
Stanisław J. Konturek Poland	59	2.1k 0.3×	2.8k 0.4×	6.5k 1.2×	794 0.3×	1.5k 0.6×	493	14.3k
Vay Liang W. Go United States	65	1.6k 0.3×	3.0k 0.5×	4.8k 0.9×	3.3k 1.1×	1.8k 0.6×	270	16.2k
Gozoh Tsujimoto Japan	70	2.5k 0.4×	9.6k 1.5×	2.4k 0.5×	1.1k 0.4×	2.8k 1.0×	336	18.0k
Keith A. Sharkey Canada	76	4.5k 0.7×	4.1k 0.6×	4.6k 0.9×	496 0.2×	1.4k 0.5×	338	20.8k
Masato Kasuga Japan	96	1.7k 0.3×	18.3k 2.8×	7.8k 1.5×	3.5k 1.2×	5.5k 2.0×	555	35.0k
Frank Reimann United Kingdom	76	2.7k 0.4×	8.7k 1.3×	7.2k 1.4×	924 0.3×	7.9k 2.9×	266	22.1k

Countries citing papers authored by Thomas E. Adrian

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Adrian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Adrian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Adrian more than expected).

Fields of papers citing papers by Thomas E. Adrian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Adrian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Adrian. The network helps show where Thomas E. Adrian may publish in the future.

Co-authorship network of co-authors of Thomas E. Adrian

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Adrian. A scholar is included among the top collaborators of Thomas E. Adrian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Adrian. Thomas E. Adrian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Collin, Peter D., et al.. (2025). Anti-inflammatory effects of Frondanol, a nutraceutical extract from Cucumaria frondosa, via modulation of NF-κB and MAPK pathways in LPS-induced RAW 264.7 cells. Frontiers in Pharmacology. 16. 1683630–1683630.

Venkataraman, Balaji, Shreesh Ojha, Saeeda Almarzooqi, et al.. (2023). Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies. Molecules. 28(7). 2982–2982. 17 indexed citations

Venkataraman, Balaji, Saeeda Almarzooqi, Bhoomendra A. Bhongade, et al.. (2023). Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation. International Journal of Molecular Sciences. 24(7). 6160–6160. 31 indexed citations

Venkataraman, Balaji, Saeeda Almarzooqi, Pradeep K. Dudeja, et al.. (2022). α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study. PPAR Research. 2022. 1–22. 16 indexed citations

Almarzooqi, Saeeda, Balaji Venkataraman, Karuna M. Das, et al.. (2022). β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways. Molecules. 27(24). 8744–8744. 14 indexed citations

Venkataraman, Balaji, Saeeda Almarzooqi, Veedamali S. Subramanian, et al.. (2021). Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor. Nutrients. 13(4). 1343–1343. 30 indexed citations

Venkataraman, Balaji, Saeeda Almarzooqi, Shreesh Ojha, et al.. (2020). Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models. Nutrients. 12(7). 2032–2032. 21 indexed citations

Uddin, Mohammed, Farah Mustafa, Tahir A. Rizvi, et al.. (2020). SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses. 12(5). 526–526. 198 indexed citations

Jayaprakash, Petrilla, et al.. (2014). Effects of a sucrose‐enriched diet on the pattern of gene expression, contraction and Ca²⁺ transport in Goto–Kakizaki type 2 diabetic rat heart. Experimental Physiology. 99(6). 881–893. 19 indexed citations

10.

Călinescu, Ioan, et al.. (2012). Saccharomyces cerevisiae immobilization in polyacrylamide hydrogel obtained at low temperature.. ROMANIAN BIOTECHNOLOGICAL LETTERS. 17(5). 7628–7638. 3 indexed citations

11.

Kennedy, Timothy J., Chung Yip Chan, Xianzhong Ding, & Thomas E. Adrian. (2003). Lipoxygenase inhibitors for the treatment of pancreatic cancer. Expert Review of Anticancer Therapy. 3(4). 525–536. 19 indexed citations

12.

Schmied, Bruno M., Alexis Ulrich, Hosei Matsuzaki, et al.. (2000). Biologic instability of pancreatic cancer xenografts in the nude mouse. Carcinogenesis. 21(6). 1121–1127. 14 indexed citations

13.

Kazakoff, Katherine, et al.. (1998). The Intracellular Mechanism of Insulin Resistance in the Hamster Pancreatic Ductal Adenocarcinoma Model. Pancreas. 17(4). 359–366. 13 indexed citations

14.

Adrian, Thomas E., John Thompson, & Eamonn Martin Quigley. (1996). Enteric neuropeptide abnormalities following small bowel resection and the effect of a tapering and lengthening procedure.. PubMed. 28(5). 2552–3. 2 indexed citations

15.

Pring‐Åkerblom, Patricia, et al.. (1995). Sequence Characterization and Comparison of Human Adenovirus Subgenus B and E Hexons. Virology. 212(1). 232–236. 34 indexed citations

16.

Goodlad, Robert A., W Lenton, M. A. Ghatei, et al.. (1987). Proliferative effects of 'fibre' on the intestinal epithelium: relationship to gastrin, enteroglucagon and PYY.. Gut. 28(Suppl). 221–226. 51 indexed citations

17.

Adrian, Thomas E., et al.. (1986). GALANIN INFUSION IN MAN - PHARMACOKINETICS AND ITS EFFECT ON GLUCOSE-METABOLISM. UCL Discovery (University College London). 1 indexed citations

18.

Adrian, Thomas E., et al.. (1986). PHARMACOKINETICS OF GALANIN IN MAN AND ITS EFFECT ON GLUCOSE-HOMEOSTASIS. UCL Discovery (University College London). 1 indexed citations

19.

Long, Richard, Thomas E. Adrian, & S.R. Bloom. (1985). Somatostatin and the dumping syndrome.. BMJ. 290(6472). 886–888. 42 indexed citations

20.

Adrian, Thomas E. & Stephen R. Bloom. (1985). The continuing hormonal contamination of insulin. Practical Diabetes International. 2(6). 34–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact